Prenatal and new-born genetic testing Market - Global Industry Analysis

Prenatal and new-born genetic testing Market - By Technology (Screening and Diagnostic), By End-Use (Hospitals, Maternity & Specialty Clinics, and Diagnostic Units), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2028

Published Date: 05-Aug-2021 Category: Biotechnology Report Format : PDF Pages: 125 Report Code: ZMR-6563 Status : Published

The global Prenatal and new-born genetic testing market accrued earnings worth approximately 4.7(USD Billion) in 2020 and is predicted to gain revenue of about 10.11(USD Billion) by 2028, is set to record a CAGR of nearly 11.8% over the period from 2021 to 2028.

Description

Prenatal and new-born genetic testing Market: Industry Perspective

The global Prenatal and new-born genetic testing Market accrued earnings worth approximately 4.7(USD Billion) in 2020 and is predicted to gain revenue of about 10.11(USD Billion) by 2028, is set to record a CAGR of nearly 11.8% over the period from 2021 to 2028. The report offers an assessment and analysis of the Prenatal and newborn genetic testing market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).

Report Scope :

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Prenatal and New-born Genetic Testing Market: Overview

Prenatal testing is referred to as medical tests performed during pregnancy to determine genetic disorders as well as birth defects in the fetus. Generally, these tests are carried out for detecting Tay-Sachs disease, sickle cell anemia, cystic fibrosis, and Down’s syndrome. Screening is continued post-baby birth and this testing is named newborn genetic testing. It is performed for determining genetically inherited disorders and phenylketonuria, critical congenital heart ailment, hearing loss, and muscular spinal atrophy. Prenatal and newborn genetic screening helps in reducing infant mortalities and enhances patient health by enabling effective diagnosis & treatment.

Prenatal and New-born Genetic Testing Market: Growth Drivers

Technological breakthroughs in healthcare & growing awareness about the advantages of prenatal & newborn genetic testing activities will steer prenatal and newborn genetic testing market growth. The surge in chromosomal disorders and the occurrence of hereditary diseases will propel business growth. In addition to this, a prominent rise in acceptance of non-invasive prenatal testing activities will scale up the expansion of the prenatal and newborn genetic testing industry size during the forecast timeline. The growing occurrence of genetic disorders in infants has translated into the need for prenatal and newborn genetic testing activities, thereby driving prenatal and newborn genetic testing market trends. However, ethical issues pertaining to prenatal & newborn genetic testing and cultural barriers can impede the growth of the prenatal and newborn genetic testing industry growth over the years ahead.

Prenatal and new-born genetic testing Market: Regional Landscape

North America To Maintain Market Dominance During Forecast Timespan

The regional market dominance of North America over 2021-2028 can be due to supportive government healthcare policies along with the easy availability of new bio-techniques including real-time PCR and multiplex PCR systems. Apart from this, the rise in cases of genetic diseases in infants and demand for minimally invasive genetic screening in countries such as the U.S. will create lucrative growth avenues for the prenatal and newborn genetic testing market in North America over the forecast period. The surge in pregnancies in women after 35 years has posed a risk of a child being born with anomalies and this has prompted the need for prenatal and newborn genetic testing activities, thereby promulgating growth in the size of the prenatal and newborn genetic testing market in the North American sub-continent.

Prenatal and new-born genetic testing Market: Competitive Landscape

Key participants profiled in the report and influencing market growth are Natera, Ariosa Diagnostics (Roche), Trivitron Healthcare, Sequenom, Berry Genomics, Qiagen, BGI, Biorad, Illumina, Laboratory Corporation of America, and Verinata Health.

The global Prenatal and new-born genetic testing Market is segmented as follows:

By Technology

  • Screening
  • Diagnostic

By End-Use

  • Hospitals
  • Maternity & Specialty Clinics
  • Diagnostic Units

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Prenatal and new-born genetic testing Market, 2018–2028(USD Billion)
    • 2.2. Prenatal and new-born genetic testing Market: Snapshot
  • Chapter 3. Global Prenatal and new-born genetic testing Market–Industry Analysis
    • 3.1. Prenatal and new-born genetic testing Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Technulogical Innovations in medical sector & awareness about benefits of prenatal & new-born genetic testing will spur prenatal and new-born genetic testing market size.
      • 3.2.2. Rise in chromosomal disorders and surge in cases of hereditary disorders will impel market space.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Technology
      • 3.4.2. Market attractiveness analysis By End-Use
  • Chapter 4. Global Prenatal and new-born genetic testing Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Prenatal and new-born genetic testing Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Technology launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Prenatal and new-born genetic testing Market– Technology Analysis
    • 5.1. Global Prenatal and new-born genetic testing Market overview: By Technology
      • 5.1.1. Global Prenatal and new-born genetic testing Market share, By Technology, 2020 and 2028
    • 5.2. Screening
      • 5.2.1. Global Prenatal and new-born genetic testing Market by Screening, 2018–2028(USD Billion)
    • 5.3. Diagnostic
      • 5.3.1. Global Prenatal and new-born genetic testing Market by Diagnostic, 2018–2028(USD Billion)
  • Chapter 6. Global Prenatal and new-born genetic testing Market– End-Use Analysis
    • 6.1. Global Prenatal and new-born genetic testing Market overview: By End-Use
      • 6.1.1. Global Prenatal and new-born genetic testing Market share, By End-Use, 2020 and 2028
    • 6.2. Hospitals
      • 6.2.1. Global Prenatal and new-born genetic testing Market by Hospitals , 2018–2028(USD Billion)
    • 6.3. Maternity & Specialty Clinics
      • 6.3.1. Global Prenatal and new-born genetic testing Market by Maternity & Specialty Clinics, 2018–2028(USD Billion)
    • 6.4. Diagnostic Units
      • 6.4.1. Global Prenatal and new-born genetic testing Market by Diagnostic Units, 2018–2028(USD Billion)
  • Chapter 7. Company Profiles
    • 7.1. Natera
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Technology Portfolio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Trivitron Healthcare
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Technology Portfolio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. Sequenom
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Technology Portfolio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Development
    • 7.4. Berry Genomics
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Technology Portfolio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Development
    • 7.5. Qiagen
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Technology Portfolio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Development
    • 7.6. BGI
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Technology Portfolio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Development
    • 7.7. Illumina
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Technology Portfolio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Development
    • 7.8. Biorad
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Technology Portfolio
      • 7.8.4. Business Strategy
      • 7.8.5. Recent Development
    • 7.9. Laboratory Corporation of America
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Technology Portfolio
      • 7.9.4. Business Strategy
      • 7.9.5. Recent Development
    • 7.10. Verinata Health
      • 7.10.1. Overview
      • 7.10.2. Financials
      • 7.10.3. Technology Portfolio
      • 7.10.4. Business Strategy
      • 7.10.5. Recent Development
    • 7.11. Ariosa Diagnostics (Roche)
      • 7.11.1. Overview
      • 7.11.2. Financials
      • 7.11.3. Technology Portfolio
      • 7.11.4. Business Strategy
      • 7.11.5. Recent Development

Table Of Figures

List of Figures

1. Market research Type
2. Market research methodology
3. Global Prenatal and new-born genetic testing Market, 2018–2028(USD Billion)
4. Porter’s Five Forces Analysis
5. Global Prenatal and new-born genetic testing Marketattractiveness, By Technology
6. Global Prenatal and new-born genetic testing Marketattractiveness, By End-Use
7. Global Prenatal and new-born genetic testing Marketshare by Technology ,2020 and 2028 (USD Billion)
8. Global Prenatal and new-born genetic testing Marketby Screening, 2018–2028(USD Billion)
9. Global Prenatal and new-born genetic testing Marketby Diagnostic, 2018–2028(USD Billion)
10. Global Prenatal and new-born genetic testing Marketshare by End-Use ,2020 and 2028 (USD Billion)
11. Global Prenatal and new-born genetic testing Marketby Hospitals , 2018–2028(USD Billion)
12. Global Prenatal and new-born genetic testing Marketby Maternity & Specialty Clinics, 2018–2028(USD Billion)
13. Global Prenatal and new-born genetic testing Marketby Diagnostic Units, 2018–2028(USD Billion)
14. Global Prenatal and new-born genetic testing Marketshare, by Region, 2020 and 2028
15. North America Prenatal and new-born genetic testing Market, 2018–2028(USD Billion)
16. Europe Prenatal and new-born genetic testing Market, 2018–2028(USD Billion)
17. Asia Pacific Prenatal and new-born genetic testing Market, 2018–2028(USD Billion)
18. Latin America Prenatal and new-born genetic testing Market, 2018–2028(USD Billion)
19. The Middle East and Africa Prenatal and new-born genetic testing Market, 2018–2028(USD Billion)
 


Table Of Tables

List of Tables

1. Global Prenatal and new-born genetic testing Market: snapshot
2. Drivers of the Prenatal and new-born genetic testing Market: impact analysis
3. North America Prenatal and new-born genetic testing Market revenue, By Technology  ,2018–2028(USD Billion)
4. North America Prenatal and new-born genetic testing Market revenue, By End-Use  ,2018–2028(USD Billion)
5. The U.S. Prenatal and new-born genetic testing Market revenue, By Technology  ,2018–2028(USD Billion)
6. The U.S. Prenatal and new-born genetic testing Market revenue, By End-Use  ,2018–2028(USD Billion)
7. Rest of North America Prenatal and new-born genetic testing Market revenue, By Technology  ,2018–2028(USD Billion)
8. Rest of North America Prenatal and new-born genetic testing Market revenue, By End-Use  ,2018–2028(USD Billion)
9. Europe Prenatal and new-born genetic testing Market revenue, By Technology  ,2018–2028(USD Billion)
10. Europe Prenatal and new-born genetic testing Market revenue, By End-Use  ,2018–2028(USD Billion)
11. UK Prenatal and new-born genetic testing Market revenue, By Technology  ,2018–2028(USD Billion)
12. UK Prenatal and new-born genetic testing Market revenue, By End-Use  ,2018–2028(USD Billion)
13. France Prenatal and new-born genetic testing Market revenue, By Technology  ,2018–2028(USD Billion)
14. France Prenatal and new-born genetic testing Market revenue, By End-Use  ,2018–2028(USD Billion)
15. Germany Prenatal and new-born genetic testing Market revenue, By Technology  ,2018–2028(USD Billion)
16. Germany Prenatal and new-born genetic testing Market revenue, By End-Use  ,2018–2028(USD Billion)
17. Rest of Europe Prenatal and new-born genetic testing Market revenue, By Technology  ,2018–2028(USD Billion)
18. Rest of Europe Prenatal and new-born genetic testing Market revenue, By End-Use  ,2018–2028(USD Billion)
19. Asia Pacific Prenatal and new-born genetic testing Market revenue, By Technology  ,2018–2028(USD Billion)
20. Asia Pacific Prenatal and new-born genetic testing Market revenue, By End-Use  ,2018–2028(USD Billion)
21. China Prenatal and new-born genetic testing Market revenue, By Technology  ,2018–2028(USD Billion)
22. China Prenatal and new-born genetic testing Market revenue, By End-Use  ,2018–2028(USD Billion)
23. Japan Prenatal and new-born genetic testing Market revenue, By Technology  ,2018–2028(USD Billion)
24. Japan Prenatal and new-born genetic testing Market revenue, By End-Use  ,2018–2028(USD Billion)
25. India Prenatal and new-born genetic testing Market revenue, By Technology  ,2018–2028(USD Billion)
26. India Prenatal and new-born genetic testing Market revenue, By End-Use  ,2018–2028(USD Billion)
27. Rest of Asia Pacific Prenatal and new-born genetic testing Market revenue, By Technology  ,2018–2028(USD Billion)
28. Rest of Asia Pacific Prenatal and new-born genetic testing Market revenue, By End-Use  ,2018–2028(USD Billion)
29. Latin America Prenatal and new-born genetic testing Market revenue, By Technology  ,2018–2028(USD Billion)
30. Latin America Prenatal and new-born genetic testing Market revenue, By End-Use  ,2018–2028(USD Billion)
31. Brazil Prenatal and new-born genetic testing Market revenue, By Technology  ,2018–2028(USD Billion)
32. Brazil Prenatal and new-born genetic testing Market revenue, By End-Use  ,2018–2028(USD Billion)
33. Rest of Latin America Prenatal and new-born genetic testing Market revenue, By Technology  ,2018–2028(USD Billion)
34. Rest of Latin  America Prenatal and new-born genetic testing Market revenue, By End-Use  ,2018–2028(USD Billion)
35. The Middle East and Africa Prenatal and new-born genetic testing Market revenue, By Technology  ,2018–2028(USD Billion)
36. The Middle East and Africa Prenatal and new-born genetic testing Market revenue, By End-Use  ,2018–2028(USD Billion)
37. Saudi Arabia Prenatal and new-born genetic testing Market revenue, By Technology  ,2018–2028(USD Billion)
38. Saudi Arabia Prenatal and new-born genetic testing Market revenue, By End-Use  ,2018–2028(USD Billion)
39. South Africa Prenatal and new-born genetic testing Market revenue, By Technology  ,2018–2028(USD Billion)
40. South Africa Prenatal and new-born genetic testing Market revenue, By End-Use  ,2018–2028(USD Billion)
41. Rest of the Middle East & Africa Prenatal and new-born genetic testing Market revenue, By Technology  ,2018–2028(USD Billion)
42. Rest of the Middle East & Africa Prenatal and new-born genetic testing Market revenue, By End-Use  ,2018–2028(USD Billion)


 

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

Technological breakthroughs in healthcare & growing awareness about advantages of prenatal & new-born genetic testing activities will steer prenatal and new-born genetic testing market growth. Surge in chromosomal disorders and occurrence of hereditary diseases will propel business growth. In addition to this, a prominent rise in acceptance of non-invasive prenatal testing activities will scale up expansion of prenatal and new-born genetic testing industry size during forecast timeline. Growing occurrence of genetic disorders in infants has translated into need for prenatal and new-born genetic testing activities, thereby driving prenatal and new-born genetic testing market trends.

According to Zion market research report, the global Prenatal and new-born genetic testing market accrued earnings worth approximately 4.7(USD Billion) in 2020 and is predicted to gain revenue of about 10.11(USD Billion) by 2028, is set to record a CAGR of nearly 11.8% over the period from 2021 to 2028.

North America will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is due to supportive government healthcare policies along with easy availability of new bio-techniques including real-time PCR and multiplex PCR systems. Apart from this, rise in cases of genetic diseases in infants and demand for minimally invasive genetic screening in countries such as the U.S. will create lucrative growth avenues for prenatal and new-born genetic testing market in North America over forecast period. Surge in pregnancies in women after 35 years has posed a risk of child being born with anomalies and this has prompted need for prenatal and new-born genetic testing activities, thereby promulgating growth in size of prenatal and new-born genetic testing market in North American sub-continent.     

 

The key market participants include Natera, Ariosa Diagnostics (Roche), Trivitron Healthcare, Sequenom, Berry Genomics, Qiagen, BGI, Biorad, Illumina, Laboratory Corporation of America, and Verinata Health.

 

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed